Home/Health Plans/Employers/OnTrak Members/Contact Us
/
         
Blog Home  
  » Home  
  Recent Posts  
 
 
 
  Blog Calendar  
 
SuMoTuWeThFrSa
   1234
567891011
12131415161718
19202122232425
262728293031 
 
  Catasys Newsletter  
  Get the latest in healtcare news. » Sign Up Now  

Welcome to the Catasys On Healthcare Blog
Substance dependence drives significant health care costs for payors through a combination of factors that include acute inpatient utilization and unaddressed co-morbidities. The Substance Dependence problem is pervasive, largely untreated and costly. Stay informed on these topics by visiting our blog periodically. You can also sign up for the Catasys On Healthcare Newsletter to receive the latest in health care news. » Sign Up for Newsletter


Raymond Anton, Medical University of South Carolina, Charleston, SC

Catasys Health - Saturday, August 01, 2009

Randomized, Stratified, Double-Blind, Placebo-Controlled Trial of Flumazenil and Gabapentin for the Treatment of Alcohol Dependence
Published in the Journal of Clinical Psychopharmacology, August 2009; 29(4):334-342.

 The OnTrak Medical Treatment Program achieved a significant reduction in use and cravings among members with symptoms of alcohol withdrawal (>6 CIWA) when compared to placebo.

Among members with more symptoms of alcohol withdrawal, the Prometa group experienced: ยป More
| 1 |

 
 
  Tags
 
drug addicts behavioral health care services alcohol prescriptions Catasys nicotine alcohol treatment flumazenil predictive modeling Harold Urschel hospital primary care dependence issues stimulants heroin stratified cocaine treatment drinking substance dependence opiates drug treatment substance dependence health insurance SD health insurance meth social network Opioid Medications alcohol dependence randomized ADHD painkillers UnitedHealthcare cigarettes ER opioid abuse contract opioid overdose withdrawal Co Occurring Disorders over-the-counter substances opioid antagonist craving score mental health methamphetamine craving identification Opioid Treatment reducing craving pain killers bipolar disorder drug abuse communication health reform relapse placebo Health Care Utilization substance dependence costs depression opiod abuse cocaine trauma physician- patient relations behavioral health care SD members opiod-based opioid reduction in craving double-blind chronic pain medical costs recovery CIWA suboxone relapse prevention alcohol drinking Research Across America PTSD Raymond Anton pain medication medical and behavioral costs hydrocodone sober Opioid Prescribing narcotic post-traumatic stress disorder pain pills binge drinking emergency room sobriety recovery network high-utilizing methamphetamine dependence Journal of Psychopharmacology alcoholism behavioral healthcare services marijuana treatment reduction in use addict morphine percocet gabapentin fentanyl facebook drug use vivitrol mental illness sugar psychosocial muscle relaxant behavioral healthcare drug addiction addiction treatment buprenorphine placebo-controlled naloxone health insurance urine drug screen prometa codeine medical methadone overdose health plan anxiety OxyContin hospitalizations behavioral health opioid-drug interactions depression screening care coaching substance use disorder OnTrak smoking vicodin drug overdose diabetes addiction data mining oxycodone ADD stress
  Call Us Today
  866-517-1414
         
 
 
Home/News/Press/Investor Relations/Careers/BlogContact Us/Site Index/Privacy Policy/Photo Disclaimer
 
  Copyright © 2013 Catasys. All rights reserved. | 11150 Santa Monica Blvd., Suite 1500, Los Angeles, California 90025 | Toll Free: 1-866-517-1414